Dr. Said Salah Dahbour, MD

Dr. Dahbour practices at Neurology Consultant, P.A. in Hagerstown, Maryland.

Dr. Dahbour's NPI, 1942934609, was assigned on July 10, 2022. Dr. Dahbour holds Maryland license D0094948.

Dr. Dahbour's primary practice is Neurology Consultant, P.A., at 235 Mill St, Hagerstown, MD 21740 in Washington County. The practice phone is (301) 739-5959.

Dr. Dahbour's primary practice is Neurology Consultant, P.A. in Hagerstown, Maryland. Dr. Dahbour is also affiliated with Meritus Medical Center. The medical group on file is Meritus Neurology. Dmand AI also links Dr. Dahbour to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Dahbour practices, 3 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Dahbour's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Dahbour is licensed in Maryland.

CMS data shows 1,424 Medicare services from Dr. Dahbour across 14 procedure codes in 2024, for 502 Medicare patients. Medicare paid $110,674 for them.

CMS counts 502 Medicare patients who saw Dr. Dahbour in 2024. The largest group is 75 to 84, with 187 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 22% are also on Medicaid. Their average risk score is 1.55, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Dahbour's median patient age at 69, with 50% women.

In 2024, Dr. Dahbour wrote 1,166 Medicare Part D claims for 229 patients. 98% of them were for generic drugs. CMS names the drug for 997 of them, across 24 drugs with 11 or more claims each, at $21,668 in total drug cost. In 2023, CMS named 384 claims across 10 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 18 out of 100 for Dr. Dahbour for performance year 2024, reported individually. Dr. Dahbour accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 11 papers to Dr. Dahbour, published from 2013 to 2022. 2018 was the busiest year, with 2. The most frequent topics are Multiple Sclerosis, Brain and Jordan. Dr. Dahbour has published most often in Diabetol Metab Syndr. Dr. Dahbour's most frequent co-author is Malik E. Juweid, MD.

CMS Open Payments shows 93 general payments to Dr. Dahbour from 23 drug and device companies from 2023 to 2025. Food and beverage make up the largest share, 89% of the total. Alexion Pharmaceuticals, Inc. paid the most, $342.